U

AnserBio

Former names: ExoProTher Medical
Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. -
Startup Seed Founded 2017 Health Tech & Life Sciences
Last Update Mar 20, 2025 · Claimed

AnserBio Lifecycle

Cumulative Funding Raised Over Time

$750KDec 2021
$4.8MDec 2023
$4.8MJan 2020
$5.0MJan 2021
$5.7MJul 2023
$6.5MNov 2022

All Events

Seed Dec 2023
$4M
SAFE Jul 2023
$700K
Peregrine Ventures
SAFE Nov 2022
$750K
Peregrine Ventures
SAFE Dec 2021
$750K
Israel Biotech Fund (Lead)
SAFE Jan 2021
$250K
Israel Biotech Fund
SAFE Jan 2020
Undisclosed
ExitValley (Lead)